Comentarios de usuarios - Escribir una reseña
No hemos encontrado ninguna reseña en los sitios habituales.
acceptance affected American analysis anxiety Approach assess associated carrier screening Caucasians Center CF carrier screening CF carrier testing CFTR child clinical common compared Conference consent cost counseling couples cystic fibrosis carrier cystic fibrosis CF decision Department detection determine Development disease disorders evaluate factors fibrosis carrier screening frequency gene genetic testing Health heterozygote higher Hum Genet Human identified important included increased individuals Institutes of Health interest issues knowledge less lung major Maryland materials mean Medical Medicine method mutations National Institutes negative offered Office panel participation patients Pediatrics percent Ph.D physicians population population screening positive pregnancy prenatal present primary Professor providers Pueblo questions received regarding relatives reported reproductive Research response risk samples scores screening for cystic sequencing siblings subjects sweat termination test results therapy trial understanding United University women
Página 23 - Modulation of airway inflammation in cystic fibrosis: in vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. J Clin Invest 1992; 90:1296-1301.
Página 27 - It will diminish the usual complaints of frequent, loose, foul movements, protuberant abdomen and excessive appetite, it will markedly reduce the incidence of rectal prolapse and possibly secondary fecal impaction which may result in intestinal obstruction."* "Schwachman, H.. Redmond. A. and Khaw. KT: "Studies in Cystic Fibrosis— Report of 130 Patients Diagnosed Under 3 Months of Age Over a 20-Year Period : Pediatrics.
Página 23 - Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis.
Página 9 - Program Analyst Office of Medical Applications of Research National Institutes of Health Bethesda, Maryland Suzanne W.
Página 9 - Branch National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Bethesda, Maryland KENNETH V.